Browse Category

LSE:AZN News 27 June 2025 - 21 January 2026

AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus

AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus

AstraZeneca shares fell 1.15% to 13,890 pence in London as markets reacted to President Trump’s threat of new U.S. tariffs on Britain and other European countries. The FTSE 100 closed down 0.4%. AstraZeneca announced EU validation for Enhertu and a $630 million buyout of China cell-therapy rights. Investors trimmed risk ahead of possible trade retaliation.
Walmart stock pauses on MLK Day — what could move WMT when markets reopen

Walmart stock pauses on MLK Day — what could move WMT when markets reopen

Walmart shares closed Friday up 0.42% at $119.70, near record highs, ahead of its addition to the Nasdaq-100 on Tuesday. Index funds are set to rebalance as Walmart replaces AstraZeneca, which could trigger volatile trading at the open. U.S. markets will be closed Monday for Martin Luther King Jr. Day. Leadership changes at Walmart take effect Feb. 1, with an earnings report due Feb. 19.
FTSE 100 climbs on miners and AstraZeneca as record gold keeps UK stocks in play

FTSE 100 climbs on miners and AstraZeneca as record gold keeps UK stocks in play

FTSE 100 rose 0.3% to 10,170.81 in mid-morning trade, led by gains in gold miners and AstraZeneca. Spot gold hit a record $4,639.42 an ounce after U.S. inflation data missed forecasts. The FTSE 250 slipped 0.3%, showing uneven momentum. Investors are watching a pending U.S. tariffs ruling and upcoming bank earnings.
Walmart stock set for Nasdaq-100 entry as Google Gemini deal and Wing drones land

Walmart stock set for Nasdaq-100 entry as Google Gemini deal and Wing drones land

Walmart will join the Nasdaq-100 on Jan. 20, replacing AstraZeneca after shifting its listing from the NYSE. On Friday, Walmart shares rose 1.3% to $114.53. The company announced a Google Gemini shopping integration and plans to expand drone delivery with Wing to 150 more U.S. stores. U.S. markets will be closed Jan. 19 for Martin Luther King Jr. Day.
London Stock Exchange Poised for Year-End Reopen as FTSE 100 Holds Near 9,871 and 2026 IPO Hopes Build

London Stock Exchange Poised for Year-End Reopen as FTSE 100 Holds Near 9,871 and 2026 IPO Hopes Build

NEW YORK, Dec. 28, 2025, 7:52 a.m. ET — Market Closed With U.S. stock markets shut for the weekend and London also dark until Monday, investors are heading into the final stretch of 2025 with an unusually familiar year-end cocktail: thin liquidity, big cross-asset moves, and a loud debate over whether London can finally turn “capital markets reform” into actual capital markets. When the London Stock Exchange (LSE) reopens Monday, it will do so in a global backdrop where Wall Street is hovering near record territory, precious metals have been sprinting, and a growing chorus of market watchers is trying
28 December 2025
London Stock Exchange Update: FTSE 100 Near Record Highs After a Strong 2025 — What to Watch When Trading Reopens

London Stock Exchange Update: FTSE 100 Near Record Highs After a Strong 2025 — What to Watch When Trading Reopens

The London Stock Exchange remains closed for the weekend and will reopen at 8:00 a.m. London time on Monday, December 29. The FTSE 100 ended the Christmas Eve half-day at 9,870.68, down 0.2%. The index is on track for a 20.7% annual gain, outperforming the S&P 500. The Bank of England cut its policy rate to 3.75% in December.
27 December 2025
UK Stock Market Today: FTSE 100 Pauses for Boxing Day as Investors Weigh Retail Signals, Precious-Metals Surge and 2026 Outlook (26 December 2025)

UK Stock Market Today: FTSE 100 Pauses for Boxing Day as Investors Weigh Retail Signals, Precious-Metals Surge and 2026 Outlook (26 December 2025)

The London Stock Exchange is closed Friday for Boxing Day, halting UK trading after a shortened Christmas Eve session where the FTSE 100 slipped 0.2%. Investors are watching global moves and a spike in precious metals, which could impact London-listed miners when trading resumes. BP agreed to sell a 65% stake in Castrol to Stonepeak for about $6 billion. The FTSE 100 is on track for a roughly 21% gain in 2025.
UK Stock Market Preview for 26 December 2025: Boxing Day Closure, FTSE 100 Drivers, Sterling Moves, Oil Pressure and the BoE Outlook

UK Stock Market Preview for 26 December 2025: Boxing Day Closure, FTSE 100 Drivers, Sterling Moves, Oil Pressure and the BoE Outlook

London — 25 December 2025. UK investors heading into Friday, 26 December 2025 should start with one practical reality: there is no standard London cash equity session tomorrow. From there, attention shifts to what’s been moving the FTSE 100, the pound, commodities and rate expectations into year-end — and what could matter most when trading resumes. Is the UK stock market open on 26 December 2025? No. The London market is closed on Boxing Day (Friday, 26 December 2025). Several brokers and market schedules list 26 December as a UK market closure, with UK equities not trading in the usual
United Kingdom Stock Market Today: FTSE 100 Holiday Pause, BP Castrol Deal and 2026 Outlook (25 Dec 2025)

United Kingdom Stock Market Today: FTSE 100 Holiday Pause, BP Castrol Deal and 2026 Outlook (25 Dec 2025)

London — Thursday, 25 December 2025. The United Kingdom stock market is closed today for Christmas Day, putting a temporary pause on trading after a holiday-shortened run into the break. With the London Stock Exchange (LSE) also shut on Friday for Boxing Day, the next meaningful read on UK risk appetite will come when markets reopen after the long weekend. MoneyWeek Even with the screens dark, investors are still digesting a busy late-December backdrop: a Bank of England rate cut to 3.75%, a strong year for UK large caps, record-setting moves in industrial metals that boosted miners, and headline corporate
25 December 2025
GSK’s Emma Walmsley Hails US as ‘Best Place to Invest’ as UK Pharma Faces Tariffs, Rebate Cuts and a Fight for Jobs

GSK’s Emma Walmsley Hails US as ‘Best Place to Invest’ as UK Pharma Faces Tariffs, Rebate Cuts and a Fight for Jobs

On 11 December 2025, outgoing GSK chief executive Dame Emma Walmsley sent a stark message to Westminster and the City: for big drug makers, the United States is now the premier destination for investment – and Britain is at risk of slipping further behind. In a broadcast interview, Walmsley praised the US as the world’s most attractive market for new medicines, saying it remains the leading arena for launching innovative drugs and vaccines and the “best place to invest” for global pharma. She also pointed to China as the other key growth market for business development. The Guardian+1 Her comments
11 December 2025
UK Stocks to Buy Today (9 December 2025, 8:30 GMT): 9 FTSE Shares to Watch as London Trades Near Record Highs

UK Stocks to Buy Today (9 December 2025, 8:30 GMT): 9 FTSE Shares to Watch as London Trades Near Record Highs

The UK stock market is starting Tuesday’s session within touching distance of all‑time highs. By around 08:20 GMT, the FTSE 100 was trading just under 9,650, essentially flat on the day but up about 15.5% over the last 12 months, with a 52‑week range of 7,544–9,930 points. FT Markets+1 At the same time, many strategists still describe UK equities as “cheap” versus other major markets. Recent analysis suggests the FTSE 100 is trading on roughly 12–13x forecast 2026 earnings compared with about 14x for the Euro Stoxx 600 and over 21x for the S&P 500, while UK blue‑chips continue to offer
Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

As of 5 December 2025, UK equities are quietly having one of their best years in over a decade. The FTSE 100 is up around 22–23% year-to-date (including dividends) and sits less than 2% below its record closing high, according to analysis from AJ Bell and Investing.com. MoneyWeek+1 Today, the FTSE 100 is up about 0.2% and the FTSE 250 about 0.4%, with AstraZeneca, Ocado, Watches of Switzerland and Greggs among the day’s notable risers, while energy majors BP and Shell drag on the index. ReutersAt the same time, markets are betting that the Bank of England will cut Bank Rate from 4% to 3.75% on 18 December, with economists expecting
Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

Current News Stock Price and Market Activity CRSP is trading around the mid-$60s ahead of Monday’s open. By Reuters (Nov 2) it was ~$64.04 (up +4.86% on the day) Reuters. (Nasdaq closes on Oct 31 showed ~$63.99 Reuters.) Over the past month CRSP has gained roughly 17% Genengnews, boosted by recent data releases. For example, a 3-day rally in mid-Oct lifted CRSP ~5% after the SyNTase/CTX460 results were announced Genengnews. Technical indicators are mixed: the 14-day RSI is ~50 (neutral) and the MACD is slightly negative Investing. Shorter moving averages (5/10/20-day around $63–$63.8) are giving buy signals Investing, but the
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began a Phase I/II study in 2024, with initial first-in-human data expected in late 2025. Wave Life Sciences’ RNA base-editing drug WVE-006 showed proof-of-mechanism in humans in 2024, and multi-dose trial data are anticipated in 2025. In April 2025, the FDA approved Abeona Therapeutics’ Zevaskyn, the first cell-based gene therapy for the rare skin disorder RDEB, with launch planned in Q3

Stock Market Today

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

7 February 2026
SAP SE closed at 171.22 euros on Xetra Friday, up 0.43%, after disclosing its treasury shares rose above 5% of capital, reaching 61,737,035 shares. The increase follows the launch of a buyback plan worth up to 2.6 billion euros through July 2026. SAP’s U.S. shares finished at $203.34. Investors await SAP’s Integrated Report on Feb. 26 and next results on April 23.
Go toTop